Skip to content

Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant

Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06606184
Enrollment
78
Registered
2024-09-20
Start date
2022-01-01
Completion date
2023-12-31
Last updated
2024-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplant Surgery

Keywords

liver transplant, pulmonary rehabilitation, inspiratory muscle training, inspiratory muscle strength, Dyspnea

Brief summary

The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients. The main questions it aims to answer are: Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery? Does the intervention improve pulmonary function and reduce dyspnea sensation? Participants performed: Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise

Detailed description

Patients undergoing liver transplantation often face significant challenges related to pulmonary rehabilitation. Although postoperative rehabilitation has been extensively studied, the specific role of pulmonary rehabilitation programs has received limited attention. This study aims to evaluate the efficacy of a home-based pulmonary rehabilitation program in improving respiratory function recovery among post-liver transplant patients. The training group participated in a 12-week pulmonary rehabilitation program post-discharge, emphasizing respiratory muscle and exercise training, while the control group received standard care, which included traditional rehabilitation.

Interventions

PROCEDUREInspiratory muscle Training

Participants underwent a 12-week program consisting of inspiratory muscle training twice daily, incentive spirometry three times daily, and upper limb exercises along with marching in place for 30 minutes.

PROCEDURERoutine Care

Participants received routine care, which included encouragement to use incentive spirometry three times daily.

Sponsors

Chang Gung University of Science and Technology
CollaboratorOTHER
Chang Gung Memorial Hospital
CollaboratorOTHER
Chang Gung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 20 years or older * Scheduled to undergo living donor liver transplantation * Stable vital signs * Normal cognitive function * Able to perform activities independently using their own strength and coordination * Willing and able to participate in 12 weeks of rehabilitation training

Exclusion criteria

* Severe physical illness during the operation * Acute bleeding * Unstable vital signs * Hepatic encephalopathy, or neurological conditions such as stroke, Parkinson's disease, or cognitive dysfunction * Limited mobility (e.g., unable to stand, lift upper limbs, or bedridden) * Inability to comply with 12 weeks of pulmonary rehabilitation post-discharge * Unstable vital signs * Hepatoencephalopathy, such as cardiovascular accident, Parkinson disease, cognitive dysfunction * Those with limited mobility (unable to stand, unable to lift upper limbs, or bedridden) * Those who are unable to cooperate with the 12 weeks of pulmonary rehabilitation exercises after discharge.

Design outcomes

Primary

MeasureTime frameDescription
Respiratory Muscle Stregnth TestThroughout the study completion, approximately 3 monthRespiratory muscle strength was determined by Maximum Inspiratory Pressure (MIP) using a pressure monometer.

Secondary

MeasureTime frameDescription
Oxygenation statusParticipants underwent maximum inspiratory and expiratory pressure measurements at four time points: upon admission, before discharge from the intensive care unit, before discharge from the hospital, and at the end of the 12-week enrollment period.Oxygen saturation was monitored using a pulse oximeter.
Dyspnea Severity AssessmentThroughout the study completion, approximately 3 monthDyspnea severity was assessed by a rating of perceived exertion, using the Borg Scale which ranged from 0 (no respiratory difficulty) to 10 (extreme respiratory difficulty), with higher scores indicating more severe breathing difficulty.
Forced Vital CapacityThroughout the study completion, approximately 3 monthThe forced vital capacity was obtained, using spirometry, by having the patient take a deep breath and then exhale forcefully. The test results were based on three reproducible measurements.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026